Company Overview
Snapshot
Founded in July 2017, Amber Medical operates with 1–10 employees. The company has raised $1 million across one funding round. Amber Medical is currently in the clinical trial stage for its medical device technology.
Business overview
Amber Medical is a Health Tech & Life Sciences company focused on developing solutions for long-term thrombosis prevention. The company's core technology involves applying a negatively charged, quasi-permanent electret coating to existing stents, enabling them to prevent in-stent thrombosis. Amber Medical operates within the medical devices sector, serving the healthcare industry, particularly doctors and hospitals, with a focus on cardiology and cardiovascular applications globally.
Log in to access full profile ›Company Intelligence Q&A
- What is Amber Medical's primary focus?
- Amber Medical is focused on long-term thrombosis prevention, specifically developing a solution that allows existing stents to prevent in-stent thrombosis through a unique electret coating.
- When was Amber Medical founded?
- Amber Medical was founded in July 2017.
- What is the current product stage of Amber Medical's technology?
- Amber Medical's medical device technology is currently in the clinical trial stage, indicating it is undergoing testing to evaluate its safety and efficacy before potential market release.
- How much funding has Amber Medical raised?
- Amber Medical has raised a total of $1 million in a single Seed funding round in January 2018.
- What sector does Amber Medical operate in?
- Amber Medical operates in the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Treatment & Therapeutics.